[Preliminary findings on clinical and immunological effects of subcutaneously administered interleukin-2 + alpha-interferon combination in the treatment of advanced renal carcinoma].
Buda
F
F
Servizio di Oncologia Medica, Ospedale S. Maria dei Battuti, USL 9 Sanvitese, San Vito al Tagliamento.
Buda
C
C
Croatto
T
T
Costa
B
B
Aragona
P
P
Tuveri
G
G
D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000633:toxicity; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000633:toxicity; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013997:Time Factors
D016898:Interferon-alpha; D007376:Interleukin-2
Risultati preliminari sugli effetti clinici ed immunologici dell'associazione interleuchina-2 + alfa interferone per via sottocutanea nel trattamento del carcinoma renale avanzato.